Clinical Trial Update: Topotecan and Melphalan for Retinoblastoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating topotecan and melphalan for retinoblastoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Drugs mentioned

• Melphalan (Melphalan)
• Topotecan (topotecan)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Retinoblastoma, Chemotherapy Effect | Phase 3 | Status: RECRUITING